Novel and known microsatellite markers within the β-globin cluster to support robust preimplantation genetic diagnosis of β-thalassemia and sickle cell syndromes

Hemoglobin. 2011;35(1):56-66. doi: 10.3109/03630269.2010.544620.

Abstract

Preimplantation genetic diagnosis (PGD) for β hemoglobinopathies has become the most common application among monogenic disorders. We present the identification of microsatellite markers [short tandem repeats (STRs)] closely linked to the β-globin gene for incorporation within PGD protocols, with the aim of increasing the number of transferable embryos. Nine candidate STRs were identified in-silico, of which three were selected based on rate-of-heterozygosity, polymerase chain reaction (PCR) efficiency and size. The multiplex reaction (β-globin gene and selected STRs, all within <0.4 Mb from the β gene) was optimized in single lymphocytes, and subsequently applied in 38 PGD cycles in couples at-risk for transmitting β hemoglobinopathies. In conclusion, incorporation of closely linked polymorphic microsatellite markers <0.4 Mb from the β-globin gene, facilitates robust assignment of β hemoglobinopathy genotypes, increasing the number of transferrable embryos otherwise rejected due to allele-drop-out (ADO), at the mutation-specific locus, compared to results based on disease-mutation genotyping alone (p < 0.001).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Anemia, Sickle Cell / diagnosis
  • Anemia, Sickle Cell / embryology
  • Anemia, Sickle Cell / genetics*
  • Blastomeres
  • Cytogenetic Analysis
  • Embryo Transfer
  • Female
  • Genotype
  • Heterozygote
  • Humans
  • Microsatellite Repeats / genetics*
  • Mutation
  • Polymerase Chain Reaction / methods*
  • Pregnancy
  • Preimplantation Diagnosis / methods
  • Single-Cell Analysis / methods
  • Syndrome
  • beta-Globins / genetics*
  • beta-Thalassemia / diagnosis
  • beta-Thalassemia / embryology
  • beta-Thalassemia / genetics*

Substances

  • beta-Globins